| Active Not Recruiting | A Study to Evaluate the Efficacy and Safety of Taldefgrobep Alfa in Participants With Spinal Muscular Atrophy Spinal Muscular Atrophy, Neuromuscular Diseases, SMA | Phase 3 | 2022-07-06 |
| Completed | Autologous Memory-like NK Cell Therapy With BHV-1100 and Low Dose IL-2 in Multiple Myeloma Patients Multiple Myeloma | Phase 1 | 2021-10-21 |
| Terminated | Long-term Safety Study of Adjunctive Troriluzole in Subjects With Obsessive Compulsive Disorder Obsessive Compulsive Disorder | Phase 3 | 2021-03-30 |
| Completed | Efficacy and Safety Study of Adjunctive Troriluzule in Obsessive Compulsive Disorder Obsessive-Compulsive Disorder | Phase 3 | 2021-01-29 |
| Completed | Efficacy and Safety Study of Adjunctive Troriluzole in Obsessive Compulsive Disorder Obsessive-Compulsive Disorder | Phase 3 | 2020-12-22 |
| Completed | Study of BHV-3241 in Participants With Multiple System Atrophy Multiple System Atrophy | Phase 3 | 2019-07-29 |
| Active Not Recruiting | Troriluzole in Adult Participants With Spinocerebellar Ataxia Spinocerebellar Ataxias, Spinocerebellar Ataxia Type 1, Spinocerebellar Ataxia Type 2 | Phase 3 | 2019-03-08 |
| Completed | Randomized Trial of Adult Participants With Generalized Anxiety Disorder Generalized Anxiety Disorder | Phase 3 | 2019-02-19 |
| Completed | Study of BHV-4157 in Alzheimer's Disease Alzheimer Disease | Phase 2 | 2018-07-31 |
| Completed | Open-label Study to Evaluate Safety, Tolerability and PK of BHV-0223 in ALS Amyotrophic Lateral Sclerosis, ALS, Lou Gehrig Disease | Phase 1 | 2018-02-02 |
| Completed | Troriluzole (BHV-4157) in Adult Participants With Obsessive Compulsive Disorder Obsessive-Compulsive Disorder | Phase 2 / Phase 3 | 2017-12-19 |
| Completed | Trial in Adult Participants With Spinocerebellar Ataxia (SCA) Spinocerebellar Ataxias, Spinocerebellar Ataxia Genotype Type 1, Spinocerebellar Ataxia Genotype Type 2 | Phase 2 / Phase 3 | 2016-12-15 |
| Available | Expanded Access Protocol of Troriluzole in Patients With Spinocerebellar Ataxia (SCA) SCA, Spinocerebellar Ataxias | — | — |
| No Longer Available | Expanded Access Protocol of BHV-0223 for Patients With Amyotrophic Lateral Sclerosis (ALS) Amyotrophic Lateral Sclerosis, ALS, Lou Gehrig Disease | — | — |
| No Longer Available | Expanded Access Protocol of Verdiperstat in Patients With Multiple System Atrophy (MSA) Multiple System Atrophy (MSA) | — | — |